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Abstract
The neurexin genes (NRXN1/2/3) encode two families (a and b) of highly polymorphic presynaptic proteins that are involved
in excitatory/inhibitory synaptic balance. Recent studies indicate that neuronal activation and memory formation affect
NRXN1/2/3a expression and alternative splicing at splice sites 3 and 4 (SS#3/SS#4). Neurons in the biological clock residing
in the suprachiasmatic nuclei of the hypothalamus (SCN) act as self-sustained oscillators, generating rhythms in gene
expression and electrical activity, to entrain circadian bodily rhythms to the 24 hours day/night cycles. Cell autonomous
oscillations in NRXN1/2/3a expression and SS#3/SS#4 exons splicing and their links to rhythms in excitatory/inhibitory
synaptic balance in the circadian clock were explored. NRXN1/2/3a expression and SS#3/SS#4 splicing, levels of neurexin-
2a and the synaptic scaffolding proteins PSD-95 and gephyrin (representing excitatory and inhibitory synapses, respectively)
were studied in mRNA and protein extracts obtained from SCN of C3H/J mice at different times of the 24 hours day/night
cycle. Further studies explored the circadian oscillations in these components and causality relationships in immortalized rat
SCN2.2 cells. Diurnal rhythms in mNRXN1a and mNRXN2a transcription, SS#3/SS#4 exon-inclusion and PSD-95 gephyrin
and neurexin-2a levels were found in the SCN in vivo. No such rhythms were found with mNRXN3a. SCN2.2 cells also
exhibited autonomous circadian rhythms in rNRXN1/2 expression SS#3/SS#4 exon inclusion and PSD-95, gephyrin and
neurexin-2a levels. rNRXN3a and rNRXN1/2b were not expressed. Causal relationships were demonstrated, by use of specific
siRNAs, between rNRXN2a SS#3 exon included transcripts and gephyrin levels in the SCN2.2 cells. These results show for
the first time dynamic, cell autonomous, diurnal rhythms in expression and splicing of NRXN1/2 and subsequent effects on
the expression of neurexin-2a and postsynaptic scaffolding proteins in SCN across the 24-h cycle. NRXNs gene transcripts
may have a role in coupling the circadian clock to diurnal rhythms in excitatory/inhibitory synaptic balance.
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Introduction
Neurexins are neuron-specific cell-surface proteins [1,2] that act
in the vertebrate nervous system as trans-synaptic receptors and
have an important role in cognition [3]. In mammals, the
neurexins are encoded by three genes NRXN1, NRXN2 and
NRXN3, each has two promoters that generate longer(a) and
shorter(b) forms [1,2,3]. The neurexin genes transcripts are edited
by extensive alternative splicing at five canonical sites referred to
as SS#1 to SS#5 in a neurexins, two of which (SS#4, SS#5) are
shared with the b neurexins [3,4]. Neurexins’ immunoreactivity
has been localized mainly to pre-synaptic nerve terminals [5] while
their known ligands are found predominantly at post-synaptic sites
in target cells (i.e. neuroligins, leucine-rich repeat transmembrane
neuronal proteins, GABAA receptors, Cbln1/Glutamate receptor
delta2 and dystroglycan) or in the extracellular fluid (e.g.
neurexophilins). Binding of neurexins to their ligands form trans-
synaptic complexes which regulate glutamatergic and GABA-ergic
transmission and subsequently the excitatory/inhibitory balance in
brain networks [6–16].
We have recently demonstrated in one day-old rat brain
neurons, that activation (by depolarization) induced a reversible,
calcium-dependent splicing repression of the rNRXN2a SS#3
exon [17]. Further studies indicated that under such conditions
SS#3 and SS#4 exons splicing in rNRXN3a but not rNRXN1a
are also repressed [18]. Fear conditioning training in rats induced
in vivo significant and transient repressions of hippocampal
rNRXN1/2/3a, SS#4 splicing, attenuated levels of the excitatory
postsynaptic scaffolding protein PSD-95 and the inhibitory
postsynaptic scaffolding protein gephyrin in the hippocampus
and fear memory formation [18]. Induced neuronal activity may
thus affect NRXNs transcripts and subsequently synaptic fine
tuning.
The circadian clock residing in the brain’s suprachiasmatic
nuclei (SCNs), is responsible for the adaptation of physiological
and behavioral rhythms to the external 24 h light-dark cycle and
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attaining proper temporal order within the organism [19].
Neurons in the SCN act as self-sustained oscillators that generate
circadian rhythms in gene expression and electrical firing bursts to
encode time of day, with high firing rates during the day and lower
rates at night [20]. The core molecular clockwork in SCN neurons
is based on autoregulatory feedback loops of transcriptional
activators (CLOCK/NPAS2 and BMAL1) and inhibitors (PER1–
2 and CRY1–2) [21]. The mechanisms by which the core clock
produces synchronized rhythms in neural firing and gene
expression are postulated to involve intracellular calcium, a
second messenger that regulates many cellular processes [22]. In
principle, neuronal firing bursts may trigger synaptic remodeling
[23], and as such may be pivotal for the communication of the
day/night information to the brain and body. Indeed there are
several publications showing synaptic plasticity in SCN [24–31].
How the expression of genes encoding proteins that are relevant to
synaptic transmission is changing across the circadian cycle is
largely unknown.
Because the neurons of the circadian clock display autonomous
rhythms in activity we hypothesized that they would also display
autonomous oscillations in neurexins SS#3/SS#4 exons splicing
and subsequently impinge on excitatory/inhibitory synaptic
balance. In the present study we have thus explored circadian
patterns in NRXN1/2/3a expression and SS#3/SS#4 exons
splicing in the mouse SCN in vivo. The variations in PSD-95 and
gephyrin levels were assessed as markers of excitatory/inhibitory
synaptic balance.
To further explore the relationship between rhythms in NRXNs
expression and SS#3/SS#4 exons splicing and the synaptic
scaffold proteins we used immortalized rat SCN2.2 neurons in vitro
[32]. These cells retain most biochemical and functional properties
of the clock with internal periodicity of ,24 hours [33]. SCN2.2
cells were used to provide homogenous neuronal-derived cell
population and facilitate plasmid transfection experiments. We
show here that these cells show circadian variations in rNRXN1/2
expression and SS#3/SS#4 exons splicing and in PSD-95 and
gephyrin levels and intracellular localization. Finally, we used
siRNAs in SCN 2.2 cells to down regulate specific neurexins
transcripts for establishing their role of in the circadian rhythms in
synaptic scaffold proteins.
Results
Circadian Rhythms in NRXNs Transcripts in the C3H/J
Mouse SCN
The mRNA levels of the core clock genes mPer1, mPer2
showed robust rhythms in the mouse SCN (Fig. 1A and B). In
agreement with previous findings in animals entrained to 12:12
hours light-dark cycles [34], two synchronous peaks of mPer1 and
mPer2 transcripts were demonstrated at 2 hours before (major
peak) and 2 hours after (minor peak) the beginning of the dark
phase (ZT10 and ZT14) (Fig. 1A and B). The levels of total
mNRXN1a and mNRXN2a transcripts also varied significantly
over the 24-hour cycle (Fig. 1C and D). NRXN1a transcript levels
also displayed 2 peaks (a major peak at ZT6 and a minor at ZT14),
whereas NRXN2a displayed a main peak at ZT6 (Fig. 1C and D).
There were no significant rhythms in mNRXN3 a transcripts in
the SCN (Fig. 1E).
Fig. 2 shows the structure of theNRXNs and circadian rhythms in
mNRXN1/2/3a SS#3/SS#4 exons splicing (amount of exon
included per total transcript of a particular NRXN) in the SCN.
Because of 1 exon difference between NRXN1 and NRXN2, SS#3
alternative exons are numbered E12(NRXN1) and E11(NRXN2)
and SS#4 alternative exons are numbered E21 (NRXN1) and
Figure 1. Diurnal changes in mPer1 mPer2 and mNRXN1/2/3a
mRNA levels in the mouse SCN. C3H/J mice kept at 12:12 hours
light:dark schedules were sacrificed at different times after light onset
(Lights on at time= 0 (ZT0)). mRNA was extracted from the SCN and
subjected to real-time PCR. The amount of (A) mPer1, (B) mPer2, (C)
Total mNRXN1a, (D) Total mNRXN2a, and (E) Total mNRXN3a transcripts
per GAPDH are presented. Values are expressed as Mean +SEM. (N = 3
animals in each time point assessed in quadruplicates). Significance of
the rhythm (ANOVA) is presented on each panel. The grey bars indicate
the dark phases.
doi:10.1371/journal.pone.0037894.g001
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E20(NRXN2). We observed significant diurnal variations in
alternative exon inclusion in mNRXN1a and mNRXN2a SS#3
(E12 and E11, respectively) andmNRXN2a SS#4 (E20) transcripts
(Fig. 2A, B and E). mNRXN1a SS#3 and mNRXN2a SS#4
splicing displayed two synchronous peaks each (ZT2 and ZT10)
(Fig. 2A and E) and mNRXN2a SS#3 exon-included transcript
displayed a main peak in the dark phase (ZT22) (Fig. 2B). These
peaks did not coincide with the peak expression of the total
transcripts of these genes in the SCN (Fig. 1). There were no
significant rhythms in mNRXN3a SS#3 and SS#4 or mNRXN1a
SS#4 splicing in the SCN (Fig. 2 C, D and F).
Because neurexins impinge on excitatory/inhibitory synaptic
balance we looked at diurnal variations in the related scaffold
proteins. Figure 3 depicts the levels of gephyrin PSD-95 and
neurexin 2a protein levels in the mouse SCN at different time
points within a 24 h-cycle. Neurexin-1a levels were not assessed
due to non-availability of specific antibodies. Gephyrin levels were
significantly elevated during the dark period (ZT14-ZT22) and
minimal during the day (Fig. 3A). The levels of PSD-95 protein
rose during the day to reach peak levels at ZT14 and declined
afterwards in the dark period to minimal values at ZT18 (Fig. 3B).
Thus, both gephyrin and PSD-95 were at their peak levels at
ZT14 but whereas PSD-95 level was low during the dark hours
gephyrin levels were minimal during the light hours. The levels of
neurexin 2a protein rose during the day to reach peak levels at
ZT12 (namely ,6 hours after the peak in mNRXN2a mRNA;
Fig. 1D), and declined afterwards in the dark period to minimal
values during the day (Fig. 3C) in a similar manner to gephyrin.
Circadian Rhythms in rNRXN1/2/3 a mRNA Levels in the
SCN2.2 Cells
The role of particular splice variants in the circadian rhythms of
PSD-95 and gephyrin was further explored in vitro using SCN2.2
cells. SCN2.2 cells expressed rNRXN1a and rNRXN2a but not
rNRXN3a (Fig. 4). Also, rNRXN1b and rNRXN2b were not
detected in these cells. The mRNA levels of the core clock gene
rPer2 and of rNRXN1/2 a in the SCN2.2 cells at different times
after synchronization are presented in Figure 4. There was a
significant rhythm in expression of rPer2 in the rat SCN2.2 cells,
with peak at 24 hours after synchronization (t = 24). Thus, Per2
levels at t = 24 were significantly higher than at t = 12–18 hours
after synchronization (P,0.001 for both). As can be seen in
Figure 4, mRNA levels of rNRXN1a and rNRXN2a also varied
significantly over the 24 hour cycle and displayed synchronous
peaks at t = 24 hours. Thus, rNRXN1a level at t = 24 was
significantly higher than at t = 6, 12 and 18 h (p,0.01 for all).
rNRXN2a levels at t = 24 were significantly different than at t = 12
and 18 h (p,0.001 for both) and levels at t = 18 also differed from
those at t = 6 h (p,0.01). Mesor values of rPer2, rNRXN1a and
rNRXN2a transcript Rq levels per GAPDH were 0.96, 0.41 and
0.63, respectively.
Like SCN cells, immortalized cells from the rat suprachiasmatic
nucleus express functional melatonin receptors [35]. To evaluate
whether the changes in rNRXN1/2 expression and SS#3/SS#4
exons splicing represent clock driven rhythms we performed phase
shifting experiments, using melatonin (1027M at t = 0 for 6 h and
incubation resumed with normal medium until harvest). In the
presence of melatonin, rPer2 peak expression was advanced by,6
hours to t = 18 h (Fig. 4A). Peak rNRXN1a and rNRXN2a
transcript levels were also advanced with melatonin from t= 24 h
to t = 18. The mesor values (mean 24 h transcript levels) were not
affected (0.89, 0.31 and 0.41 for rPer2, rNRXN1a and rNRXN2a
transcripts, respectively) and rhythm amplitude, as represented by
peak/trough rNRXN1a and rNRXN2a mRNA ratios were
maintained or slightly increased under the melatonin conditions
(Fig. 4B).
Diurnal rhythms in rNRXN2a SS#3/SS#4 exons splicing
(inclusions of E11 and E20 respectively) and rNRXN1a SS#3/
SS#4 exons splicing (corresponding to inclusions of E12 and E21
respectively) in the SCN2.2 cells were also assessed (Fig. 5).
Significant rhythms were observed in rNRXN2a SS#3/SS#4
alternative splicing transcripts with synchronous peaks in E11/E20
exons inclusions at t = 18 h after synchronization (Fig. 5). Tran-
scripts levels at t = 18 h were significantly higher than at t = 6 and
t = 24 h and did not overlap the phase of peak expression of
rNRXN2a (Fig. 4). These rhythms were attenuated with
melatonin (Fig. 5). rNRXN1a SS#3 exon (E12) splicing also
demonstrated a significant diurnal oscillation with peak exon
included transcript at t = 12. Transcript level (per total rNRXN1a)
at t = 12 was significantly higher than at t = 18 and t = 24 h after
synchronization. Peak rNRXN1a SS#3 exon included transcript
(per total rNRXN1a) was delayed with melatonin to t = 18 h
(Fig. 5). rNRXN1a SS#4 exon (E21) included transcripts were not
detected in these cells.
The changes in levels of PSD-95 gephyrin and neurexin 2a with
the circadian time were also assessed in the SCN2.2 cells (Fig. 6).
Western blot analysis of the proteins indicated clear and significant
circadian rhythms in the levels of the proteins, with maximal PSD-
95 gephyrin levels at t = 12–18 h after synchronization. Minimal
levels of both protein were observed at t = 24 h. Neurexin 2a were
maximal at t = 6 h after synchronization (Fig. 6C) namely ,6
hours after the peak in rNRXN2a mRNA (Fig. 4C).
The intracellular localization of PSD-95 and gephyrin in
SCN2.2 cells at various times after synchronization, are depicted
in Fig. 6C. Immunofluorescence experiments at different hours of
the cycle using antibodies for PSD-95 (green) and gephyrin (red)
indicated that PSD-95 was mostly associated with dense clusters in
the cytoplasm at all time points. Gephyrin was mostly localized in
the peri-nuclear region but showed clear membrane staining at
t = 18 h and less so at other times. Unlike the Western blots that
demonstrated even levels of gephyrin at t = 12–18 (Fig. 6D),
gephyrin staining in the cells consistently demonstrated higher
apparent intensity at t = 18 h than at t = 12 h (Fig. 6D).
The effects of melatonin treatment on PSD-95 and gephyrin
rhythms are depicted in Figure 7. For both, significant rhythms
were still evident following 6 hours melatonin treatment (P = 0.005
for gephyrin and P=0.02 for PSD-95) without significant changes
in mesor values. Following melatonin treatment maximal PSD-
95levels shifted to at 6 h (as also at 30 h) after synchronization
(Fig. 7A). The phase shifting effects of melatonin treatment on
gephyrin was minor, and maximal levels of Gephyrin were seen at
t = 18 h after synchronization (Fig. 7B).
Gephyrin and PSD-95 Levels are Linked to NRXN2a SS#3
Exon-including Transcripts
We then used siRNA mediated suppression of rNRXN1a,
rNRXN2a and rNRXN2a SS#3 exon- included transcripts to
explore causal relationships between rhythms in neurexin genes
expression, SS#3/SS#4 alternative exons splicing and the
rhythms in PSD-95 and gephyrin. The cells transfected with the
respective siRNA were then harvested 12 (corresponding to time
of peak levels of PSD-95 and gephyrin), 18 (corresponding to time
of peak levels of NRXN2a SS#3 E11 included transcript) and 24
(corresponding to time of peak expression of rPer2 and NRXN2a)
hours after synchronization. Expression levels of total rNRXN1a,
rNRXN2a, and E11 included rNRXN2a transcripts, and
gephyrin and PSD-95 protein levels were assessed (Fig. 8).
Scrambled siRNA (SCR) was used as control in these studies.
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Figure 2. Diurnal changes in mNRXN1/2/3a SS#3/SS#4 exons splicing in the mouse SCN. Upper panel: Neurexin genes structure and
splice sites. Laminin, neurexin, sex-hormone-binding protein (LNS), epidermal growth-factor)-like (EGF), transmembrane (TM) domains, highly
glycosylated region (CH), and PDZ-domain-binding site (PDZ BD). The position of each of five alternative splicing sites is indicated (SS#1–SS#5).
Exons are identified by numbers; asterisks mark exons subject to alternative splicing. Lower panels: C3H/J mice kept at 12:12 hours light:dark
schedules were sacrificed at different times after light onset (Lights on at time= 0 (ZT0)). mRNA was extracted from the SCN and subjected to real-
time PCR. The amount of SS#3 exon included transcripts of (A) mNRXN1a, (B) mNRXN2a, (C) mNRXN3a, and of SS#4 exon included transcripts of (D)
mNRXN1a, (E) mNRXN2a, (F) mNRXN3a transcripts are expressed per total transcripts of the relevant mNRXN1/2/3a. Values are expressed as Mean
+SEM (N=3 animals in each time point assessed in quadruplicates). Significance of the rhythm (ANOVA) is presented on each panel. The grey bars
indicate the dark phases.
doi:10.1371/journal.pone.0037894.g002
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The siRNA directed at the constitutive rNRXN2a exon E8 had
no effect on rNRXN1a expression (Fig 8A) and significantly
reduced NRXN2a transcripts at all 3 time points (Fig. 8C). This
siRNA also reduced the amount of rNRXN2a E11 including
transcripts at t = 18 (a time when this transcript prevails)
significantly and to a lesser extent at t = 24 (without reaching
statistical significance compared to the scrambled siRNA control)
(Fig 8E). The suppression of rNRXN2a transcripts affected the
levels of gephyrin and PSD at t = 18 (i.e. at which rNRXN2 E11
including transcript levels were also suppressed). Thus, a
significant decrease in gephyrin and an increase in PSD-95 were
noted in the rNRXN2a siRNA treated cells at t = 18 compared to
scrambled siRNA control (Fig 8G and I). Also, in the rNRXN2a
siRNA treated cells rNRXN2 E11 including transcripts were
reduced at t = 24 (not significantly) and gephyrin levels decreased
(Fig 8G) but not at t = 12 at which rNRXN2 E11 including
transcripts and gephyrin were both unaffected.
The siRNA directed against rNRXN2 SS#3 exon (E11)
including transcripts significantly reduced the level of rNRXN2
E11 included transcripts at all time points (Fig 8F). As expected,
this siRNA also reduced the amount of rNRXN2 a transcripts at
t = 18, (at which rNRXN2 SS#3 exon (E11) included transcripts
prevail), but not at the other time points (Fig 8D). It also reduced
rNRXN1a expression at t = 12 (at which rNRXN1 SS#3 exon
(E12) included transcripts prevail, see Fig 5A) but not at the other
times (Fig 8B). The down regulation of rNRXN2 SS#3 exon (E11)
included transcripts led to significant diminution of gephyrin levels
at all times. In addition rNRXN2 E11 siRNA caused significant
upregulation of PSD-95 exclusively at t = 18 (a time at which
rNRXN2a transcript levels were also reduced). Down-regulation
Figure 3. Diurnal rhythms in synaptic scaffold proteins and neurexin 2a in the mouse SCN. C3H/J mice kept at 12:12hours light:dark
schedules were sacrificed at different times after light onset (Lights on at time= 0 (ZT0)). Proteins were extracted from the SCN and analyzed by
immunoblotting. Representative blots of A) Gephyrin B) PSD-95 and C) neurexin2a and the corresponding GAPDH at various times after lights-on (ZT)
are shown in the left panels. Quantifications of PSD-95, gephyrin and neurexin 2a levels relative to GAPDH are presented in the right panel. Values are
expressed as Mean +SEM levels of respective protein relative to GAPDH (N= 3 animals in each time point). ZT represents hours from lights-on. The
gray shaded areas indicate the dark phase. Significance of the rhythm (ANOVA) is presented on each panel.
doi:10.1371/journal.pone.0037894.g003
Circadian Rhythms in Neurexins Gephyrin and PSD95
PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e37894
of rNRXN1a with siRNA had no significant effects on PSD-95 or
gephyrin (not shown).
To further exclude off-target effects of NRXN2a and NRXN2
E11 siRNAs on gephyrin, two additional siRNAs directed at other
constitutive rNRXN2a exons (E19, E14) were tested. As expected,
only those siRNAs that reduced rNRXN2 E11 transcripts and at
the time they did so, also reduced gephyrin levels. Thus, the
siRNA directed at the constitutive rNRXN2a exon E19, did not
reduce rNRXNa2 levels at 24 h after synchronization but reduced
mean(SEM) rNRXN2 SS#3 exon (E11) included transcripts levels
to 0.54 (0.21) and gephyrin to 0.7 (0.1) of control values with
scrambled siRNA. The siRNAs directed at the constituti-
verNRXN2a exon E14 reduced rNRXN2a to 0.79(0.14) but not
Figure 4. Circadian variations in rPer2, rNRXN1a and rNRXN2a expression in synchronized SCN2.2 cells and the effects of
melatonin on them. Cells (6 plates each) were synchronized and incubated with vehicle (left panels) or 100 nM melatonin (right panels) for 6 hours
and collected at different time points during 24 hours (6 plates each). A) rPer2; B) Total rNRXN1a C) Total rNRXN2a qPCR values are normalized vs.
rGAPDH. Significance of the rhythms (ANOVA) is denoted on each panel.
doi:10.1371/journal.pone.0037894.g004
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rNRXN2a SS#3 exon E11 -included transcripts at 18 h after
synchronization and did not affect gephyrin levels significantly.
Discussion
This study demonstrates diurnal variations in expression and
SS#3/SS#4 splicing of mNRXN1a and mNRXN2a (but not
NRXN3a) neurexin-2a and postsynaptic scaffolding proteins
(PSD-95 and gephyrin) levels in the mouse SCN in vivo.
Neurexin-2a protein peak appeared ,6 hours after the mRNA
peak. Rhythmic expression and SS#3/SS#4 exons splicing of
rNRXN1a and rNRXN2a (NRXN3a is not expressed) was also
observed in rat SCN2.2 cells in vitro. Being found in SCN samples
from mouse and SCN-derived cells from rat, these rhythms appear
to be a general rather than species- specific trait of SCN cells.
In the SCN in vivo, we observed traces of two different
oscillations in clock control genes (mPer1 and mPer2) and in
mNRXN1/2 genes, by which transcripts reached two peaks, one
in the late light phase and another at the beginning of the dark
phase. Such split was already demonstrated previously in mice
Figure 5. Circadian variations in rNRXN1a and rNRXN2a SS#3/SS#4 splicing in SCN2.2 cells and the effects of melatonin on them.
Cells (6 plates each) were synchronized and incubated with vehicle (left panels) or 100 nM melatonin (right panels) for 6 hours and followed up
afterwards for 24 hours. The amount of SS#3 exon included transcripts of (A) ) rNRXN1a, (B) rNRXN2a, and of SS#4 exon included transcripts of (C)
rNRXN2a, transcripts are expressed per Total transcript of the relevant rNRXN1/2a. Significance of the rhythm (ANOVA) is denoted on each panel.
doi:10.1371/journal.pone.0037894.g005
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kept in 12:12 light: dark cycles as in our experiment [34]. Some
evidence could also be noted in other publications [36,37]. The
early peaks in mPer1 and mPer2 were ascribed to the posterior
SCN and the later one to the anterior SCN [34] or to existence of
separate oscillating cell groups in mouse suprachiasmatic nucleus
that couple photoperiodicity to the onset and end of daily activity
[34]. A recent paper [38] concluded that in the living SCN tissue
individual cells undergo an oscillation in expression of genes and
proteins as they participate in complex interactions across the
circadian cycle. In this sense they are clearly ‘oscillating cells’, but
their temporal behavior depends critically on their location in the
SCN tissue, most probably as a reflection of intercellular
communication. The precise timing of PER2 expression within
individual neurons is dependent on their location within the
nucleus, and that small groups of neurons within the SCN give rise
to distinctive and identifiable sub-regions.
The intrinsic nature of the rhythms in rNRXN1/2a expression
and SS#3/SS#4 exons splicing is demonstrated in rat immortal-
ized SCN2.2 cells in culture and the ability of melatonin to phase
shift them as it does for the core clock components (e.g. Per2) [35].
As SCN2.2 cells act as self sustained pacemakers [32] these results
suggest that these rhythms are cell- autonomous. NRXN1a and
NRXN2a genes do not include E- box sequences in their
promoters and therefore cannot be regarded as primary clock-
controlled genes [39]. The rhythms in expression of NRXN1a and
NRXN2a and their alternative SS#3/SS#4 exons splicing thus
reveal an additional layer of post-transcriptional regulation of
clock controlled genes in mammals as recently found in plants
(Arabidopsis) and flies (drosophila) [40].
The rhythm in PSD-95 in the SCN2.2 cells appears to be
causally linked to the clock (as it was shifted/modified following
melatonin treatment. The rhythm in gephyrin appears to be less
dependent on clock phase. It was influenced by NRXN2a SS#3
exon (E11)-included transcript levels and was consistently modified
following specific NRXN2a E11 siRNA treatments. With
altogether 6 different siRNAs (one scrambled, one targeting
rNRXN1, and four targeting rNRXN2 Exons E8, E11, E14 and
E19) only those that reduced rNRXN2 E11 transcripts levels and
at the times they did so, caused down regulation of gephyrin.
Moreover, down regulation of rNRXN2a expression using siRNA
directed against a constitutive exon (e.g. E8) resulted in
suppression of gephyrin selectively at times when E11 including
transcripts comprised most of the NRXN2a mRNA (t = 18 h).
The rNRXN2a E11 SiRNA also reduced the levels of NRXN1a
mRNA at t = 12 (a time when the SS#3 exon (E12) included
transcripts prevail). However, as down regulation of rNRXN1a by
Figure 6. Circadian rhythms in synaptic scaffold protein and neurexin 2a levels and intracellular localization in the SCN2.2 cells.
Cells (6 plates each) were synchronized and collected every 6 hours (6 plates each). Proteins were extracted from the cells and analyzed by SDS PAGE
and Western blotting. Protein levels of Gephyrin (A) PSD-95 (B) and neurexin 2a (C) were quantified by immunoblots and normalized to GAPDH levels.
Values are Mean +SEM; N= 3 cultures in each time point. Significance of the rhythm (ANOVA) is denoted on each panel. Representative blots of (D)
Gephyrin (E) PSD-95 and (F) neurexin2a. The respective GAPDH blots from the same gels (D1, E1 and F1) at various times after synchronization are
also depicted. G) SCN2.2 cells were seeded over Poly-L-Lysine coated cover slips, synchronized and fixed by 4% paraformaldehyde after different
hours (T = 2–30 h). Cells were immunostained for PSD-95 and Gephyrin, and nuclei were stained with Hoechst staining. An example of membrane
staining is noted by a white arrow.
doi:10.1371/journal.pone.0037894.g006
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specific SiRNA did not affect gephyrin, NRXN1 is probably not
involved in the down regulation of gephyrin at t = 12.
Notably, the % of inhibition is calculated from the amount of
transcript/protein in the siRNA treated cells to respective values in
SCR treated cells at the same time after synchronization. As the
amounts of total transcripts of the two neurexins as well as synaptic
scaffolds proteins vary with the circadian cycle and at different
phases, it is not surprising that the % inhibition at a certain time
point may differ for the mRNA transcripts and protein levels.
Therefore a high percentage at one time may be related to a small
change in actual transcript or protein levels and vice versa. For
example, at 12 hours most of the rNRXN2 is in the E11 excluded
form and therefore even for an equal reduction in total NRXN2,
that reduction is presumably in the E11 excluded form and would
not lead to decrease in gephyrin at this hour (Fig. 8E). PSD-95
levels were not affected by changes in rNRXN2a E11 transcripts
but upregulated under conditions that total rNRXN2a mRNA
transcripts were suppressed. The effects on the synaptic scaffold
proteins appear to be specific for NRXN2a as down-regulation of
NRXN1a was not associated with significant changes in PSD-95
or gephyrin. Beside diurnal fluctuations in protein levels, gephyrin
also exhibited diurnal rhythms in intracellular localization moving
between the perinuclear region, the cytoplasm and plasma
membrane. Considering the limitations of immunostaining tech-
nique as a quantitative method, the results obtained using these
different methods are reasonably consistent. However, at t = 12 h
after synchronization gephyrin immunostaining intensity appeared
to be less than expected according to the western blot data. At this
time gephyrin was mostly associated with the cytoplasm. The most
obvious explanation for the apparent discrepancy is that the two
antibodies (the one used in the immunoblotting and the one used
in the immunostaining) differ in their affinities to some unspecified
gephyrin isoforms. This remains to be further investigated.
This study suggests a link between the expression of certain
NRXN splice variants to excitatory/inhibitory synapse scaffolds in
the biological clock. Because there are currently no antibodies
capable of detecting the specific variants of native neurexins
(comprising ,1000 isoforms), it was only possible to demonstrate
circadian rhythms in total endogenous neurexin-2a and show that
it followed peak NRXN2a transcripts by ,6 h in both SCN in
vivo and in the SCN2.2 cells in vitro. Nevertheless, the data in our
study demonstrates that the clock controlled changes in certain
endogenous NRXNs transcripts are eventually translated into
changes in synaptic proteins. The molecular mechanisms linking
the circadian clock to the control of RNA processing is compatible
with emerging evidence suggesting that regulation at the RNA
level strongly impacts the cellular circadian transcriptome and
proteome as well as the oscillator mechanism itself [41].
What our study also shows is that the cross-talk between Nrxn2a
E11 included transcripts and the inhibitory synapse scaffold
protein Gephyrin are fast enough to be involved in synaptic
plasticity over the 24 hours period. Emerging evidence suggests
that the entire synaptic structure, including scaffolding proteins
and vesicles, is highly dynamic during both development and
periods of plasticity. Indeed, SCN oscillations are associated with
plastic changes in configuration of the SCN cell network
[28,29,31,42,43]. Furthermore, it appears that some of these
changes involve inhibitory synapses. [44,45]. Dynamics of
GABAergic synaptic components have been studied previously
over milliseconds to minutes, revealing mobility of postsynaptic
scaffolds and receptors. [46,47,48]. Recent studies in both
vertebrate and invertebrate models have shown time-of-day effects
on neurophysiology and memory formation, and have revealed a
possible role for cycling molecules in memory persistence
(reviewed in [49]). Together, these studies suggest that common
mechanisms underlie circadian rhythmicity and long-term mem-
ory formation. The rhythmic expression and SS#3/SS#4 exons
splicing of NRXNs and the effects of NRXNs on the expression of
postsynaptic scaffolding proteins in SCN neurons across the light-
dark cycle may link the circadian clock to diurnal oscillations in
balance of excitatory/inhibitory neurotransmission.
Materials and Methods
Animals and Sample Acquisition
All animal experiments were conducted in accordance with a
protocol approved by the Policy on the Use of Animals in
Neuroscience Research, the Policy on Ethics, by the Society for
Neuroscience, and were consistent with Federal Guidelines and
the European Communities Council Directive (89/609/EEC).
Animal and sample acquisition was performed as described
previously [50]. Male C3H/J mice (Charles River, Sulzbach,
Germany) aged 8–12 weeks were used in all experiments. At least
2 weeks prior to experiments, animals were housed under a
standard light-dark (LD) regimen, with 12-h light (250 lux; light on
designated as Zeitgeber time [ZT0] and 12-h darkness (dim red
Figure 7. Effects of melatonin on the rhythms in synaptic scaffold protein levels in the SCN2.2 cells. Cells (6 plates each) were
synchronized and incubated with vehicle (circles) or 100 nM melatonin (triangles) for 6 hours and collected every 6 hours (6 plates each). Proteins
were extracted from the cells and analyzed by SDS PAGE and Western blotting. Protein levels of Gephyrin (A) and PSD-95 (B) were quantified by
immunoblots and normalized to GAPDH levels. Values are Mean +SEM; N=3 cultures in each time point. Significance of the rhythm (ANOVA) is
denoted on each panel.
doi:10.1371/journal.pone.0037894.g007
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light ,10 lux, .680 nm), with constant room temperature, and
food and water available ad libitum. Tissue sampling was carried
out at ZT2, 6, 8, 10, 12, 14, 18, and 22 (three animals per time
point). After decapitation of animals at indicated time points, the
brain was removed. The isolation of the SCN essentially followed
published procedures [19,51]. Briefly, after brain removal, 500 mm
thick slices of the suprachiasmatic region were prepared with a
manual tissue chopper. When the desired level of SCN has been
reached (the SCN at this point appears as more defined, round or
almond shaped structures) sections containing the SCN were cut
from the slices under a binocularly microscope using scalpels and
surrounding tissue was carefully removed. The isolated SCN
tissues were immediately frozen on dry ice. Subsequently, RNA
and protein extraction was performed using the NucleoSpinH
RNA/Protein kit according to manufacturer’s protocol. (Ma-
cherey-Nagel, Du¨ren, Germany). VersoTM RT-PCR Kit (Thermo
scientific, ABgene, Epsom, UK) was used for cDNA synthesis,
from 250 ng of total RNA using Oligo(dT) primer, according to
manufacturer’s protocol.
SCN2.2 Cell Culture and Sample Acquisition
SCN2.2 Immortalized rat SCN cells, obtained from Dr. David J
Earnest [32] were plated onto 6-well plastic tissue culture plates
(36105/well) and grown for 48 h to confluence in minimal
essential medium (MEM) supplemented with 10% fetal bovine
serum (FBS), 4mM L-Glutamine, 4 mg/mL glucose (Merck,
Germany), penicillin (100U/mL) and streptomycin (0.1 mg/mL)
(all from Biological Industries, Beth Haemek, Israel) at 37oC in
humidified atmosphere with 5% CO2. Synchronization was
performed essentially as described [52]. Growth medium was
replaced with medium containing 5% FBS for at least 8 hr prior to
the synchronizing pulse. The medium was then removed, and cells
were rinsed with calcium-magnesium free (CMF) Buffer (Dulbec-
co’s PBS (1X) w/o Ca2+ or Mg+ (Sigma)) containing 2 mg/mL
glucose, and incubated for 1 hr in serum free medium. The serum-
free MEM medium was then replaced with growth medium and
cells were kept in this medium until harvested at 6 hours intervals
over 30 hours. Samples were subjected to RNA extraction using
MasterPureTM Kit (EPICENTRE, Madison, USA), according to
manufacturer’s protocol. VersoTM RT-PCR Kit (ABgene Nucleic
Acid Amplification, Epson, UK) was used for cDNA synthesis,
from 1 mg of total RNA using Oligo (dT) primer according to
manufacturer’s protocol. Synchrony was checked by measuring
circadian rhythms in RPer2 mRNA expression using real time
PCR. Proteins extraction was performed using Radio Immuno
Precipitation Assay buffer (RIPA lysis buffer; 150 mM sodium
chloride, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS
(sodium dodecyl sulphate) 50 mM Tris, pH 8.0) with Protease
Inhibitor Cocktail (Sigma-Aldrich, MO, USA). Cell suspension
was maintained for 20min in ice, following centrifugation at 4uC
for 10min at maximum speed. Supernatant was removed to a new
cold tube, and proteins amount was measured spectrophotomet-
rically with Bradford reagent at 595 nm (Bio-Rad laboratories,
CA, USA).
RNA Interference
SCN2.2 cells were plated into 6-well plates, and transfected
24 h later with 40nM of siRNA duplexes specific for rNRXN1 and
for rNRXN2 exons E8, E11, E18, E19, and scrambled negative
control siRNAs as a mock transfection (IDT technologies) with
8mL of INTERFERin transfection reagent (Polyplus-transfection
Inc., NY, USA) according to the manufacturer’s instructions
(Mirus Bio, Madison, USA). Cells were synchronized 48 hr after
transfection and sampled after the indicated period of time in
hexaplicates. Samples were harvested for RNA and protein
extraction RT-PCR and real-time PCR experiments.
Real Time PCR
Real-time PCR analysis was performed using ABI PRISM 7300
(Applied Biosystems, California, US) and KAPA SYBRH FAST
ABI PrismH 2X qPCR Master Mix (Kapa Biosystems, Boston,
US), according to the instruction of the manufacturer. Each PCR
reaction mixture contained 1 mL of cDNA template mix. The
primers used for real time PCR analysis are depicted in Table 1.
Gene expression values for the various NRXN1/2/3a RNA and
Table 1. List of the primers that were used for qPCR.
Gene Name Primer Sequence
GAPDH Fw 5’ GACAACTTTGGCATCGTGGA
Rv 5’ ATGCAGGGATGATGTTCTGG
mPer1 Fw 5’ CAGGCTAACCAGGAATATTACC
Rv 5’ TGTCAGGAAGGACACAGCC
mPer2 Fw 5’CTGGCTTCACCATGCCTGTT
Rv 5’ AAGGCCTGAGGCAGGTTTG
NRXN1 total Fw 5’ CATTGCAAGCCTACACTTCTATGC
Rv 5’ AGGTTAGCACCATTTCCCAAGTC
NRXN1 SS#3 Fw 5’ CAGGCTATCTCGGCAGG
Rv 5’ GCTTGTTGATCATCCACG
NRXN1 SS#4 Fw 5’ GCAATGGGATGGCTTCAGCTG
Rv 5’ CGCTGTCTAGCAATCGCCAG
NRXN2 total Fw 5’ TCCAGGGACCCAGGCAAC
Rv 5’ CTTGCTCAGGCCACCGATG
NRXN2 SS#3 Fw 5’ GTCCCTGCGATTCATGTCCC
Rv 5’ CAGCCGACGCGCAGG
NRXN2 SS#4 Fw 5’ GCCCTGTCTGCAATGAC
Rv 5’ GCGCTCGTTATCAAAGTTC
NRXN3 total Fw 5’ ACTCGGGACAACAGTAATACCCAC
Rv 5’ CTGGGCTAAGCCAGCCATATAG
NRXN3 SS#3 Fw5’ CTGTATCAGGATAAACTGTAACTCC
Rv 5’ CCACATCATCGTCCACTGTT
NRXN3 SS#4 Fw 5’ CTGGAAACCAGTGCAATGACC
Rv 5’ GGCGTTCATTATCAGTGTTGC
doi:10.1371/journal.pone.0037894.t001
Figure 8. Silencing of NRXN2a and NRXN2a E11 including transcript have differential effects on gephyrin and PSD-95 levels. Total
and E11 including rNRXN2a mRNA levels were suppressed using targeted siRNA sequences (siRNA NRXN2 and siRNA NRXN2 E11 respectively), a
scrambled sequence (SCR) was used as a control. Cells were synchronized and then incubated with the siRNAs or SCR for 24 hours and harvested
12,18 or 24 hours afterwards. Mean (+SEM) mRNA levels of (A,B) total rNRXN1a, (C,D) total rNRXN2a, (E, F) E11 including rNRXN2a, and protein levels
of (G, H) gephyrin and (I, J) PSD-95 are depicted. Significant differences from control values are marked with asterisks (* p,0.05 t-test against SCR;
N = 3). (K) The respective gephyrin, PSD-95 and GAPDH blots are also depicted.
doi:10.1371/journal.pone.0037894.g008
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RNA splice variants were calculated based on the comparative
threshold cycle (Ct) method [53]. Ct data for a specific NRXN
isoform, total NRXN mRNA and the housekeeping gene GAPDH
mRNA in each sample were used to create DCt values for total
NRXN in sample (Ct total NRXN – Ct GAPDH) and specific isoform
transcripts (Ct specific NRXN isoform – Ct total NRXN). Thereafter,
DDCt values were calculated by subtracting the DCt of the
untreated control sample from the Ct value of treated sample. In
circadian rhythm assessments (wherein all samples at various time
points were under the same treatment) DDCt values were
calculated by subtracting the DCt at t = 0 from the Ct values of
other time points with the same treatment. Rq = 2(–DDCt).
Proteins Extraction and Analyses
Tissue protein samples. (10–30 mg) were subjected to
sodium-dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) using 10% acrylamide gels (Bio-rad, California, US)
followed by electroblotting onto PVDF membranes (Millipore,
Massachusetts, USA). Blots were blocked with blocking buffer (5%
non-fat dry milk in PBS with 0.1% Tween 20 (PBST)) for 1 hour at
room temperature. Blots were incubated with the relevant primary
antibody (PSD-95 ab18258 1:1000, gephyrin ab32206 1:1000,
neurexin2a ab34245 1:500 and GAPDH ab8245 1:1000, all from
ABCAM, Mass. USA) in PBS overnight at 4uC.
Cell protein samples. Aliquots (40 mg) were subjected to
SDS-PAGE on 10% acrylamide gels (Bio-rad, California, US) as
described above. Blots were washed and subsequently incubated
with secondary antibodies IRDyeH 800CW Conjugated Goat
Anti-Rabbit IgG or IRDyeH 680CW Conjugated Goat Anti-
Mouse IgG (LI-COR Biosciences, Nebraska, USA) diluted
1:10000. Membranes were scanned and analyzed using LI-COR
Odyssey (LI-COR Biosciences, Nebraska, USA).
Immunofluorescence
SCN2.2 cells (36105) were plated onto Poly-L-Lysine coated
(Sigma-Aldrich, MO, USA) cover slips, immersed in 6-well plates
and synchronized as described above. Cells were washed with
serum-free Dulbecco’s modified Eagle’s medium and fixed with
4% paraformaldehyde in phosphate-buffered saline for 45 min at
room temperature. The cells were then washed three times with
cold Hanks’ balanced salt solution (HBSS) (Biological Industries,
Beit Haemek), supplemented with 20 mM Hepes (pH 7.4) and 2%
BSA (Hepes and BSA purchased from Sigma), and permeablized
with 0.25% Triton X-100 for 5 min. Fixed cells were washed
again and incubated with normal goat c globulin 200 mg/mL,
(Jackson ImmunoResearch Laboratories, PA, USA), 30 min at
room temperature, followed by incubation in HBSS/Hepes/BSA
with primary mouse anti-PSD-95 (PSD-95 antibody [6G6–1C9]
(ab2723) Abcam, Massachusetts,USA), rabbit anti-gephyrin (ALX-
210–400 Enzo Life Sciences, PA,USA) for 1 h. Secondary labeling
was then performed using Alexa flourH 546 Donkey anti-rabbit
(Molecular Probes, Invitrogen, Oregon, USA) and cy2-goat anti-
mouse IgG (Jackson ImmunoResearch Laboratories, PA, USA) for
30 min at room temperate. Cells were washed with HBSS/Hepes,
stained with Hoechst dye (Sigma-Aldrich, MO, USA) and
mounted with Prolong gold Antifade reagent (Molecular Probes,
Invitrogen, CA, USA). Fluorescence Images were digitalized using
a LSM 510 Laser Scanning Microscope (Zeiss, USA).
Statistical Analyses
The mean (SD) values of experimental and control groups were
compared using Student’s t tests. Differences were considered
significant if P,0.05. Circadian rhythms were evaluated by one-
way ANOVA of data from samples collected at different times of
the day (P,0.05). One way (time of day) ANOVA was used to
establish the presence circadian rhythms [54]. This method
assesses whether the variance between time points is significantly
greater than the random variation within them. The analysis
requires several readings to be taken at each of a group of times
within the day; the times of assessment do not have to be evenly
spaced. Strength of the ANOVA method is that shape of the
rhythm does not affect the statistical outcome [54]. Cosinor best fit
method that is sometimes used for the analysis of circadian
rhythms was not chosen because for most of the observed rhythms
the data span is not sinusoidal in shape.
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